Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

At

Atea Pharmaceuticals Inc

AVIR · NASDAQ
AVIR · NASDAQ
3.31
USD0.072.16%

Latest News

    SeekingAlpha

    Atea Pharmaceuticals jumps on $5.75 a share takeover offer from Tang Capital

      @sspencer_smb
      sspencer_smb

      great job by traders on the desk catching #1 In Play $AVIR from inflection to R3 on the Open. tons of liquidity... https://t.co/2MD6zbKin0

      Hold

      Strong Buy

      Buy

      Hold

      Sell

      Strong Sell

      Day Range

      3.23USD
      3.37USD

      52 Week Range

      2.46USD
      4.14USD

      Market Cap

      278.13MUSD

      lock-imagelock-image

      Get Full Access with Profit PRO

      See which Billionaires own this investment

      About

      General Information

      Type

      Common Stock

      Exchange

      NASDAQ

      Currency Code

      USD

      Currency Name

      US Dollar

      Country Name

      USA

      Country ISO

      US

      ISIN

      US04683R1068

      CUSIP

      04683R106

      Sector

      Healthcare

      Industry

      Biotechnology

      Fiscal Year End

      December

      IPO date

      -

      Updated At

      -

      Highlights

      PE Ratio

      -

      PEG Ratio

      -

      Book Value

      4.80

      Dividend Share

      -

      Dividend Yield

      -

      Earnings Share

      -1.65

      Wall Street Target Price

      7.50

      EPS Estimate Current Year

      -2.02

      EPS Estimate Next Year

      -1.64

      EPS Estimate Current Quarter

      -0.4107

      EPS Estimate Next Quarter

      -0.4144

      Most Recent Quarter

      -

      Profitability

      Revenue TTM

      192,180,000

      Gross Profit TTM

      -80,826,000

      EBITDA

      -101,035,000

      Profit Margin

      0.00%

      Return On Assets TTM

      -12.77%

      Return On Equity TTM

      -30.47%

      Revenue Per Share TTM

      2.31

      Qtly Revenue Growth YOY

      295.20%

      Diluted Eps TTM

      -1.65

      Qtly Earnings Growth YOY

      264.10%

      Valuation

      Trailing PE

      0.00

      Forward PE

      0

      Price Sales TTM

      1.9026

      Price Book MRQ

      0.6766

      Enterprise Value Revenue

      58

      Enterprise Value EBITDA

      -260

      Peers analysis

      • Be
        ONCBeiGene, Ltd.

        257.51

        4.39%
      • UCB SA ADR
        UCBJYUCB SA ADR

        90.45

        1.63%
      • UCB SA
        UCBJFUCB SA

        188.94

        1.42%
      • Alnylam Pharmaceuticals Inc
        ALNYAlnylam Pharmaceuticals Inc

        313.25

        1.13%
      • Vertex Pharmaceuticals Inc
        VRTXVertex Pharmaceuticals Inc

        445.00

        0.94%
      • Regeneron Pharmaceuticals Inc
        REGNRegeneron Pharmaceuticals Inc

        512.58

        0.66%
      • argenx SE
        ARGNFargenx SE

        586.54

        0.00%
      • CSL Limited
        CMXHFCSL Limited

        148.56

        0.00%
      • CSL Ltd
        CSLLYCSL Ltd

        77.85

        -1.44%
      • argenx NV ADR
        ARGXargenx NV ADR

        540.76

        -0.27%
      XM

      Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

      Trade with a Trusted, Award-Winning Broker.

      Trading involves risk. The value of investments may go up or down. Trade responsibly.

      FAQs

      What is Atea Pharmaceuticals Inc stock price today?

      What is Atea Pharmaceuticals Inc stock ticker?

      Is AVIR stock price going up?

      What is the analyst recommendation for AVIR?

      What is AVIR market cap?

      Does AVIR release financial reports?

      When is AVIR next earnings date?

      What were AVIR Earnings for the last quarter?

      What was AVIR Revenue for the last quarter?

      What was AVIR Net Income for the last quarter?

      Does AVIR pay dividends?

      How many employees does AVIR have?

      What is AVIR EBITDA?

      How to buy AVIR stocks?

      Should I invest in AVIR stock?